SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-005412
Filing Date
2022-04-14
Accepted
2022-04-13 21:36:40
Documents
12
Period of Report
2022-04-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20220413x8k.htm   iXBRL 8-K 35058
  Complete submission text file 0001558370-22-005412.txt   154506

Data Files

Seq Description Document Type Size
2 EX-101.SCH acrs-20220413.xsd EX-101.SCH 3060
3 EX-101.LAB acrs-20220413_lab.xml EX-101.LAB 16018
4 EX-101.PRE acrs-20220413_pre.xml EX-101.PRE 10325
6 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20220413x8k_htm.xml XML 4842
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 22825851
SIC: 2834 Pharmaceutical Preparations